Form
SCHEDULE 13G
Passive or exempt beneficial ownership filing.
Deep Track Capital, LP - 19 Mar 2025 SCHEDULE 13G Report for Immunovant Inc. Common Stock, $0.0001 par value per share (IMVT)
- Filing manager
- Deep Track Capital, LP
- Reporting owner
- Deep Track Capital, LP
- Beneficially owned shares
- 9,500,000 shares
- Class ownership
- 5.6%
- Large-stake signal
-
Ownership
5.6%Beneficial ownership of this reported class.
Shares
9,500,000 sharesShares beneficially owned as disclosed.
Event date
19 Mar 2025Date tied to the ownership event or amendment.
Accepted by SEC
26 Mar 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Symbol
- IMVT
- Shares outstanding
- 169,946,333 shares
- Form type
- SCHEDULE 13G
- Accepted by SEC
- 26 Mar 2025, 16:09:37 UTC
- Event date
- 19 Mar 2025
- SEC filing
- View on sec.gov
Ownership signal
2 signals
Subject security
2 source fields
Source evidence
4 source fields
Key filing fact
Deep Track Capital, LP disclosed 5.6% ownership in Immunovant Inc. Common Stock, $0.0001 par value per share (IMVT) on 19 Mar 2025.
Key facts
- Deep Track Capital, LP filed SCHEDULE 13G for Immunovant Inc. Common Stock, $0.0001 par value per share (IMVT).
- Disclosed ownership: 5.6%.
- Date of event: 19 Mar 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 26 Mar 2025, 16:09.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (3)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 5.6% | 9,500,000 | 0 | 9,500,000 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 5.6% | 9,500,000 | 0 | 9,500,000 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 5.6% | 9,500,000 | 0 | 9,500,000 | /s/ David Kroin | David Kroin |
CIK / CUSIP context first